# SmartNOA-Controller

[![MIT License](https://img.shields.io/badge/License-MIT-blue.svg)](LICENSE)
[![medRxiv preprint coming](https://img.shields.io/badge/medRxiv-preprint_2025-red)](https://www.medrxiv.org)

**Smart NOA: A Rule-Based Closed-Loop Safety Supervisor for Multimodal Opioid-Free Anesthesia**

Open-Source Proof of Concept • MIT License • medRxiv preprint – November 2025

![](demo.gif)

## What This Is

A minimal, fully deterministic, clinically grounded Python implementation of a Software-as-a-Medical-Device (SaMD) prototype that enforces evidence-based contraindications before drug delivery and automatically stops or adjusts infusions when physiology violates safety thresholds. Every decision is traceable and citable. This is the critical bridge from academic publication to patentable medical technology.

## Why It Matters

Traditional infusion pumps have no brain. Smart NOA sits between the clinician and the pump and physically prevents known dangerous actions in real time, especially in high-risk geriatric and renally impaired patients.

## Key Features

Hard lockouts: no Dexmedetomidine in 3rd-degree heart block. Age-adjusted dose ceilings: patients over 65 years receive 50% Dexmedetomidine dose reduction. Real-time bradycardia (HR < 48 bpm) and hypotension (MAP < 60 mmHg) interlocks. Override-proof safety: pump stops even if the clinician tries to continue during active physiologic violation.

## Quick Start

```bash
python smart_noa_controller.py
```

The demo simulates a high-risk geriatric patient with heart block. The controller enforces hard contraindications, generates age-adjusted starting rates, and performs real-time hemodynamic monitoring with automatic safety interventions.

## Architecture

The controller implements a multi-variable dynamic interlock system:

**Patient State Management**: demographics, comorbidities, renal function, allergies. **Initial Contraindication Engine**: calculates hard lockouts based on patient-specific risk factors (eGFR < 30, cardiac conduction abnormalities, drug allergies). **Dose Calculation Module**: generates evidence-based starting rates with automatic age and renal adjustments. **Real-Time Physiologic Monitoring**: continuous hemodynamic surveillance with immediate safety responses.

## Clinical Protocol Implementation

**Dexmedetomidine**: standard dose 0.5 mcg/kg/hr, reduced to 0.25 mcg/kg/hr for age > 65 years. Hard contraindication in heart block. Automatic cessation if HR < 48 bpm or MAP < 60 mmHg.

**Ketamine**: subanesthetic dose 0.2 mg/kg/hr for multimodal analgesia.

**Lidocaine**: systemic dose 1.5 mg/kg/hr for opioid-sparing effect.

**Ketorolac**: hard contraindication if eGFR < 30 mL/min/1.73m² or NSAID allergy.

## Example Output

```
Smart NOA Controller initialized
Hard lockouts: ['Ketorolac', 'Dexmedetomidine']
Dexmedetomidine check → HARD LOCK: 3rd-degree heart block or severe bradycardia risk

Suggested starting protocol:
{'Lidocaine': 1.5, 'Ketamine': 0.2, 'Dexmedetomidine': 0.0}

=== Smart NOA Closed-Loop Supervision Active ===

T+ 0s | HR 67 | MAP 82 → Stable – maintaining protocol
T+ 1s | HR 45 → BRADYCARDIA → DEXMEDETOMIDINE STOPPED
T+ 2s | MAP 58 → HYPOTENSION → PAUSING INFUSIONS
```

## Citation

Preprint available November 2025:

```
Colling, George. "Smart NOA: A Deterministic Closed-Loop Safety Controller 
for Multimodal Opioid-Free Anesthesia – An Open-Source Proof of Concept." 
medRxiv (2025). DOI: pending.
```

## Patent Status

U.S. Provisional Patent Application in preparation (December 2025). Claims focus on the multi-variable dynamic interlock architecture, not the pharmaceutical agents themselves.

## License

MIT License. Fork, improve, cite, build on it. We want this to become the open standard for safe opioid-free anesthesia.

## Authors

George Colling – Department of Anesthesiology & Pain Medicine, University of Washington Medical Center

## Disclaimer

Research prototype only. Not intended for clinical use. Clinical deployment would require extensive validation testing, regulatory approval (FDA 510(k) or De Novo pathway), integration with certified medical device hardware, and prospective clinical trials. The authors assume no liability for any use of this software in clinical settings.

---

**Let's make hemodynamics boring again.**

*Powered by deterministic logic and surgical common sense.*
